Nanobiotix S.A. (NASDAQ:NBTX) Q2 2023 Earnings Conference Call September 27, 2023 8:00 AM ET

Company Participants

Craig West - SVP, IR

Laurent Levy - Co-Founder & CEO

Bart Van Rhijn - CFO

Conference Call Participants

Lucy Codrington - Jefferies

Swayampakula Ramakanth - H.C. Wainwright

Operator

Good day, and thank you for standing by. Welcome to the Nanobiotix Business Update and First Half 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a Q&A session. Please be advised that today's conference is being recorded.

At this point, I’d like to turn the call over to Craig West, Senior Vice President of Investor Relations of Nanobiotix.

Craig West

Thank you, operator. Good afternoon, and good morning, and welcome to the Nanobiotix conference call to discuss our first half 2023 financial and operating results. Joining me on the call today are Laurent Levy, Co-Founder and Chief Executive Officer; and Bart Van Rhijn, Chief Financial Officer. As a reminder, today's call is being webcast and will be available on our website for replay.

I would like to remind you that this call will include forward-looking statements, which may include statements regarding the progress, success, and timing of our ongoing and planned clinical trials, collaborations, regulatory filings, dates of presentation, and future research and development efforts among other things.

These forward-looking statements are based on current information, assumptions, and expectations that are subject to change. They are subject to significant risks and uncertainties that could cause the company's actual results to differ materially from our current expectations. Accordingly, you are cautioned not to place undue reliance on forward-looking statements.

Please review the full description of risk factors that can be found in the documents we filed with the AMF in France, and SEC in the United States, including the RFS and 6-K filed yesterday, both of which are available in the Investor Relations section of our website, along with the press release issued yesterday, highlighting our corporate and financial results for the period.

In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, Nanobiotix undertakes no obligation to update them to reflect subsequent events or future circumstances.

With that said, I'd like to turn the call over to Laurent. Please go ahead.